PROFOUND MEDICAL CORP (PROF) Stock Income Statement
NASDAQ:PROF - Nasdaq - CA74319B5027 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.68M | 7.20M | 6.68M | 6.87M | 7.30M | |||
| Cost Of Goods | 3.64M | 2.82M | 3.66M | 3.92M | 3.83M | |||
| Gross Profit | 7.04M | 4.38M | 3.02M | 2.95M | 3.47M | |||
| Operating Expenses | 40.10M | 33.00M | 32.62M | 33.24M | 22.34M | |||
| Research and Development | 16.96M | 14.38M | 14.69M | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 23.13M | 18.62M | 17.93M | 17.97M | 12.43M | |||
| Operating Income | -33.06M | -28.62M | -29.60M | -30.29M | -18.86M | |||
| Interest Income/Expense | 5.24M | 65.00K | 3.45M | 145.00K | -2.62M | |||
| Other Income/Expense | N/A | -146.00K | 290.00K | -448.00K | -90.00K | |||
| Non Recurring Items | N/A | 0.00 | -2.52M | N/A | N/A | |||
| Income Before Taxes | -27.82M | -28.70M | -28.38M | -30.59M | -21.58M | |||
| Income Tax | -2.00K | -128.00K | 287.00K | 105.00K | 45.00K | |||
| Net Income | -27.82M | -28.57M | -28.67M | -30.70M | -21.62M | |||
| EBITDA | -32.13M | -27.47M | -28.00M | -28.41M | -17.32M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.12 | -1.35 | -1.38 | -1.50 | -1.25 | |||
| Non GAAP EPS | -1.12 | -1.35 | -1.38 | -1.50 | -1.22 | |||
| Statistics | ||||||||
| Gross Profit Margin | 65.89% | 60.87% | 45.22% | 42.95% | 47.56% | |||
| Profit Margin | -260.45% | -396.85% | -429.11% | -446.66% | -296.03% | |||
| Operating Profit Margin | -309.57% | -397.50% | -443.08% | -440.72% | -258.26% | |||
All data in USD